Home › Companies › IDEAYA BIOSCIENCES INC. › 2024-2025

IDEAYA BIOSCIENCES INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and IDEAYA BIOSCIENCES INC.’s Form 8-K, filed June 24, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.

4Ballot items
230Asset managers
986Fund votes
June 24, 2025Meeting date

Results at a glance

Meeting of June 24, 2025: 4 items on IDEAYA BIOSCIENCES INC.’s Form 8-K, filed June 24, 2025: 4 without a stated outcome.

Material dissent

Elect Director: Scott W. Morrison 54.7% of votes cast Outcome not stated Director under 80%

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore IDEAYA BIOSCIENCES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by IDEAYA BIOSCIENCES INC.

These tallies are IDEAYA BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 24, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

IDEAYA BIOSCIENCES INC. — official shareholder meeting results, meeting held June 24, 2025
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Jeffrey L. Stein, Ph.D.	69,077,770	--	--	7,955,948	3,030,741	90%	Not verified	—
Elect Director: Scott W. Morrison	42,132,938	--	--	34,900,780	3,030,741	54.7%	Not verified	—
2. The ratification of the selection, by the Audit Committee of the Board of Directors of the Company, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2025	79,645,454	228,609	190,397	--	--	99.7%	Not verified	—
3. The non-binding, advisory vote to approve the compensation of the Company's named executive officers	59,798,805	17,040,207	194,706	--	3,030,741	78%	Not verified	—

Source: IDEAYA BIOSCIENCES INC., Form 8-K, filed with the SEC on June 24, 2025 — read the filing on EDGAR.

How asset managers voted at the IDEAYA BIOSCIENCES INC. 2024-2025 meeting

Each item below shows how the 230 asset managers that disclosed a IDEAYA BIOSCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Jeffrey L. Stein, Ph.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%

FOR: 69,077,770WITHHELD: 7,955,948

Details: description as filed, official tally, votes by 63 asset managers

Description as filed by funds: To elect two Class III directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Jeffery L. Stein. Ph.D.

IDEAYA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Jeffrey L. Stein, Ph.D.”): 69,077,770 for, 7,955,948 withheld, per its Form 8-K filed June 24, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 63 asset managers below reported 31,449,325 for, 3,886,787 withheld.

FOR

FOR: 31,449,325WITHHOLD: 3,886,787

Largest asset managers voting on “To elect two Class III directors to hold office until the 2028 annual meeting of stockholders or until their s” at IDEAYA BIOSCIENCES INC., 2024-2025
Asset manager	For	Withheld	Vote
Fidelity	9,391,044	34,685	For
Vanguard	4,962,217	0	For
Federated Hermes	4,628,526	0	For
BlackRock	614,085	3,378,609	Mixed
Capital Group	2,844,923	0	For
JANUS INVESTMENT FUND	2,008,303	0	For
T. Rowe Price	1,658,054	0	For
State Street	1,489,014	0	For
MUTUAL FUND SERIES TRUST	771,844	0	For
Charles Schwab	717,322	0	For
Aberdeen	441,305	0	For
TIAA	284,311	0	For
GENERAL AMERICAN INVESTORS CO INC	260,261	0	For
Equitable	6,083	234,426	Withhold
Victory Capital	157,644	0	For
New York Life	156,939	0	For
QUANTITATIVE MASTER SERIES LLC	0	148,647	Withhold
Jackson National	131,090	534	For
Exchange Place Advisors Trust	115,150	0	For
Tema ETF Trust	65,134	0	For
Lincoln Financial	63,900	359	For
ALPS ETF Trust	61,002	0	For
MASTER INVESTMENT PORTFOLIO	56,544	0	For
Global X	52,366	0	For
Brighthouse	29,941	19,953	Mixed

Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.

2. Elect Director: Scott W. Morrison

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

54.7% Majority: yes · of votes cast

FOR 54.7%WITHHELD

FOR: 42,132,938WITHHELD: 34,900,780

Details: description as filed, official tally, votes by 63 asset managers

Description as filed by funds: To elect two Class III directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Scott W. Morrison

IDEAYA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Scott W. Morrison”): 42,132,938 for, 34,900,780 withheld, per its Form 8-K filed June 24, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 54.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 63 asset managers below reported 22,484,073 for, 12,852,039 withheld.

FORWITHHOLD

FOR: 22,484,073WITHHOLD: 12,852,039

Largest asset managers voting on “To elect two Class III directors to hold office until the 2028 annual meeting of stockholders or until their s” at IDEAYA BIOSCIENCES INC., 2024-2025
Asset manager	For	Withheld	Vote
Fidelity	9,283,366	142,363	For
Vanguard	4,962,217	0	For
Federated Hermes	0	4,628,526	Withhold
BlackRock	0	3,992,694	Withhold
Capital Group	2,844,923	0	For
JANUS INVESTMENT FUND	2,008,303	0	For
T. Rowe Price	1,658,054	0	For
State Street	4,262	1,484,752	Withhold
MUTUAL FUND SERIES TRUST	771,844	0	For
Charles Schwab	0	717,322	Withhold
Aberdeen	0	441,305	Withhold
TIAA	284,311	0	For
GENERAL AMERICAN INVESTORS CO INC	260,261	0	For
Equitable	6,083	234,426	Withhold
Victory Capital	0	157,644	Withhold
New York Life	138,424	18,515	Mixed
QUANTITATIVE MASTER SERIES LLC	0	148,647	Withhold
Jackson National	131,090	534	For
Exchange Place Advisors Trust	0	115,150	Withhold
Tema ETF Trust	65,134	0	For
Lincoln Financial	0	64,259	Withhold
ALPS ETF Trust	0	61,002	Withhold
MASTER INVESTMENT PORTFOLIO	0	56,544	Withhold
Global X	0	52,366	Withhold
Brighthouse	0	49,894	Withhold

Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.

3. 3. The non-binding, advisory vote to approve the compensation of the Company's named executive officers

Outcome not verified Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 12 wordings of this item as funds reported it.

78% Majority: yes · of votes cast

FOR 78%AGAINST

FOR: 59,798,805AGAINST: 17,040,207

Details: description as filed, official tally, votes by 230 asset managers

Description as filed by funds: To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders.

IDEAYA BIOSCIENCES INC.’s own tally for this item (“3. The non-binding, advisory vote to approve the compensation of the Company's named executive officers”): 59,798,805 for, 17,040,207 against, per its Form 8-K filed June 24, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 78% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 63 asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as di” at IDEAYA BIOSCIENCES INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
Fidelity	9,391,044	34,685	0	For
Vanguard	4,962,217	0	0	For
Federated Hermes	4,628,526	0	0	For
BlackRock	614,085	3,378,609	0	Mixed
Capital Group	0	2,844,923	0	Against
JANUS INVESTMENT FUND	2,008,303	0	0	For
T. Rowe Price	1,658,054	0	0	For
State Street	1,486,715	2,299	0	For
MUTUAL FUND SERIES TRUST	771,844	0	0	For
Charles Schwab	0	717,322	0	Against
Aberdeen	441,305	0	0	For
TIAA	284,311	0	0	For
GENERAL AMERICAN INVESTORS CO INC	260,261	0	0	For
Equitable	102,813	137,696	0	Mixed
Victory Capital	157,644	0	0	For
New York Life	138,424	18,515	0	Mixed
QUANTITATIVE MASTER SERIES LLC	0	148,647	0	Against
Jackson National	0	131,624	0	Against
Exchange Place Advisors Trust	0	115,150	0	Against
Tema ETF Trust	65,134	0	0	For
Lincoln Financial	63,900	359	0	For
ALPS ETF Trust	61,002	0	0	For
MASTER INVESTMENT PORTFOLIO	56,544	0	0	For
Global X	0	52,366	0	Against
Brighthouse	29,941	0	19,953	Mixed

Fund voting reports, all 63 managers: 27,609,715 for, 7,706,444 against, 19,953 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 189 asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as di” at IDEAYA BIOSCIENCES INC., 2024-2025
Asset manager	For	Against	Vote
Fidelity	13,129,823	0	For
Janus Henderson	5,771,888	0	For
Federated Hermes	4,628,526	0	For
BlackRock	1,007,275	2,974,125	Mixed
DEERFIELD MANAGEMENT COMPANY, L.P.	3,915,311	0	For
State Street	3,172,872	2,536	For
Capital Research Global Investors	0	2,844,923	Against
Point72	2,593,995	0	For
Logos Global Management LP	0	2,555,115	Against
T. Rowe Price	2,385,356	0	For
GEODE CAPITAL MANAGEMENT, LLC	2,111,522	0	For
PICTET ASSET MANAGEMENT SA	1,692,726	0	For
Sofinnova Investments, Inc.	1,294,000	0	For
Fiera Capital Corp	1,153,211	0	For
ADAGE CAPITAL PARTNERS GP, L.L.C.	948,694	0	For
Charles Schwab	0	718,378	Against
Fisher Asset Management, LLC	621,615	47,804	Mixed
DAFNA Capital Management LLC	651,830	0	For
Northern Trust	600,068	0	For
Redmile Group, LLC	0	490,996	Against
Aberdeen	441,305	0	For
Citadel	400,717	0	For
Avidity Partners Management LP	0	355,000	Against
NEW YORK STATE COMMON RETIREMENT FUND	0	326,572	Against
AXA INVESTMENT MANAGERS UK Ltd	0	324,020	Against

Institutional-manager reports, all 189 managers: 50,351,356 for, 12,323,428 against, 2,584 abstained, 1,620 not voted, 164,451 mixed. Showing the 25 largest; see all in the interactive database.

4. 2. The ratification of the selection, by the Audit Committee of the Board of Directors of the Company, of…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%

FOR: 79,645,454AGAINST: 228,609

Details: description as filed, official tally, votes by 63 asset managers

Description as filed by funds: To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025;

IDEAYA BIOSCIENCES INC.’s own tally for this item (“2. The ratification of the selection, by the Audit Committee of the Board of Directors of the Company, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending”): 79,645,454 for, 228,609 against, per its Form 8-K filed June 24, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 63 asset managers below reported 35,314,466 for, 1,693 against, 19,953 abstained.

FOR

FOR: 35,314,466AGAINST: 1,693ABSTAIN: 19,953

Largest asset managers voting on “To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers” at IDEAYA BIOSCIENCES INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
Fidelity	9,425,729	0	0	For
Vanguard	4,962,217	0	0	For
Federated Hermes	4,628,526	0	0	For
BlackRock	3,992,694	0	0	For
Capital Group	2,844,923	0	0	For
JANUS INVESTMENT FUND	2,008,303	0	0	For
T. Rowe Price	1,658,054	0	0	For
State Street	1,488,927	87	0	For
MUTUAL FUND SERIES TRUST	771,844	0	0	For
Charles Schwab	717,322	0	0	For
Aberdeen	441,305	0	0	For
TIAA	284,311	0	0	For
GENERAL AMERICAN INVESTORS CO INC	260,261	0	0	For
Equitable	240,509	0	0	For
Victory Capital	157,644	0	0	For
New York Life	156,939	0	0	For
QUANTITATIVE MASTER SERIES LLC	148,647	0	0	For
Jackson National	131,624	0	0	For
Exchange Place Advisors Trust	115,150	0	0	For
Tema ETF Trust	65,134	0	0	For
Lincoln Financial	64,259	0	0	For
ALPS ETF Trust	61,002	0	0	For
MASTER INVESTMENT PORTFOLIO	56,544	0	0	For
Global X	52,366	0	0	For
Brighthouse	29,941	0	19,953	Mixed

Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.

Not shown here: this season’s fund filings also report 1 item from the meeting of May 31, 2024, which belongs to the 2023-2024 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest IDEAYA BIOSCIENCES INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 87,565,252 shares outstanding at the time of that meeting.

Fund voting reports: top IDEAYA BIOSCIENCES INC. shareholders by shares voted on “To approve, on a non-binding, advisory basis, the compensation of the Company's named executive…”, 2024-2025
#	Asset manager	% of shares outstanding
1	Fidelity	10.76%
2	Vanguard	5.67%
3	Federated Hermes	5.29%
4	BlackRock	4.56%
5	Capital Group	3.25%
6	JANUS INVESTMENT FUND	2.29%
7	T. Rowe Price	1.89%
8	State Street	1.70%
9	MUTUAL FUND SERIES TRUST	0.88%
10	Charles Schwab	0.82%

Institutional-manager reports: top IDEAYA BIOSCIENCES INC. shareholders by shares voted on “To approve, on a non-binding, advisory basis, the compensation of the Company's named executive…”, 2024-2025
#	Asset manager	% of shares outstanding
1	Fidelity	14.99%
2	Janus Henderson	6.59%
3	Federated Hermes	5.29%
4	BlackRock	4.55%
5	DEERFIELD MANAGEMENT COMPANY, L.P.	4.47%
6	State Street	3.63%
7	Capital Research Global Investors	3.25%
8	Point72	2.96%
9	Logos Global Management LP	2.92%
10	T. Rowe Price	2.72%

Reported IDEAYA BIOSCIENCES INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

IDEAYA BIOSCIENCES INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
FMR (Fidelity)	15.00%	13F
FMR LLC	14.43%	DEF14A
BlackRock	10.46%	13F
JANUS HENDERSON GROUP PLC	8.30%	13G
Vanguard Group	5.82%	13F
T. Rowe Price	3.97%	13F
State Street	3.94%	13F
Federated Hermes, Inc.	3.88%	13G
Geode Capital	2.38%	13F
Point72 Asset Management, L.P.	2.11%	13G

Percentages above are of 87,565,252 shares outstanding, as reported by IDEAYA BIOSCIENCES INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from IDEAYA BIOSCIENCES INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At IDEAYA BIOSCIENCES INC.'s shareholder meeting held June 24, 2025, in the 2024-2025 proxy season, 230 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 986 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of the Company's named executive… — FOR was 78% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: IDEAYA BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 24, 2025.

IDEAYA BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.